Position in RLYB
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$12,992
+$5,709 QoQ
Shares Held
812
0.0% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#24
of 37 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLYB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Hartford Financial Management Inc. holds $725,370 across 12 Biotechnology names. RLYB ranks #5 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | FENC |
Fennec Pharmaceuticals Inc.
|
50,646 | $544,444 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
11,498 | $100,664 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
100 | $30,103 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
353 | $19,393 | |
| 5 | RLYB |
Rallybio Corp
This page
|
812 | $12,992 | |
| 6 | INCY |
Incyte Corp
|
48 | $5,441 | |
| 7 | ABUS |
Arbutus Biopharma Corp
|
900 | $4,320 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4 | $2,494 |
All Filings in RLYB
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,992 | 812 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $7,283 | 812 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $4,459 | 6,500 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $3,243 | 6,500 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $2,197 | 6,500 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $4,257 | 6,500 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $6,240 | 6,500 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $7,605 | 6,500 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $8,710 | 6,500 | Shares | Sole | 2024-08-09 | |
| No filing history on record for this holder in this stock. | ||||||